TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that it has launched Lamotrigine Extended Release Tablets, an AB-rated generic version of GlaxoSmithKline’s LAMICTAL® XR. The FDA-approved product is being supplied to TruPharma pursuant to an agreement with Handa Pharmaceuticals, LLC, (a subsidiary of Handa Pharmaceuticals, Inc.). LAMICTAL® is a registered trademark of GlaxoSmithKline.